Artificial Medical Intelligence Announces Patent for Delphi Method Process for More Accurate Computer Assisted Coding and Faster Implementation

Used with Company’s EMscribe Natural Language Processing, Targets Coding Accuracy

EATONTOWN, N.J.--()--Artificial Medical Intelligence (AMI) today announced the issuance of a United States patent for the Delphi Method Process which is an integral part of the company’s process supporting their EMscribe Computer Assisted Coding (CAC) solution.

EMscribe utilizes AMI’s innovative Natural Language Processing (NLP) technology to read inpatient and outpatient records for appropriate diagnostic, procedure and other medical terminology. By assimilating the new patented Delphi Consensus Method into its Computer Assisted Coding solution, AMI is the industry’s only solution to offer meaningful benefits in accuracy, productivity and billing compliance when compared to manual systems or industry competitors.

Simultaneously with the implementation of the EMscribe software, the Delphi Method Process is utilized to evaluate the existing coding department to generate a site specific gold standard of accuracy. The process provides an industry advantage because it first incorporates all general aspects of the site coding guidelines as an initial baseline and then derives a gold standard or “correct coding” related to accuracy. Additionally, the Delphi Method is inherently an audit process therefore giving clients immediate feedback metrics so that improvements can be measured and expectations are met.

“No other CAC vendor has been able to effectively address a coding accuracy standard for hospital satisfaction,” said Stuart Covit, COO, AMI. “Not only does the Delphi Method Process assist in rapid go-live times but the consensus modeling that AMI generates provides significant quality improvements over existing healthcare sites’ manual coding process. The Delphi Method Process has been used for a while with our current AMI customers and now that it is officially protected by the US Patent Office, we are proud to be public about our significant differentiation amongst our competitors.”

About AMI

Artificial Medical Intelligence, Inc. (AMI) is a software developer of health information technology solutions since its incorporation in 2002. AMI initially targeted the labor intensive medical coding process, with its premier offering, EMscribe®, a proprietary Natural Language Processing (NLP), Computer Assisted Coding (CAC) solution. EMscribe was first commercialized in 2005, providing a software platform for the medical coding of free text electronic documents for the inpatient and outpatient hospital environment. Through continued version updates, the EMscribe software became comprehensive for all medical record processing by provisioning for all medical record systems including ICD10CD/PCS, DSM, LOINC, PQRS and E & M. AMI has also diversified its solution to accommodate, clinics and physician practices. Additionally, the solution was augmented to provide a platform for numerous other medical language capabilities touching on revenue cycle, clinical documentation improvement and clinical decision making enhancements vital for the efficient information gathering and support of the medical record for the healthcare industry.

Contacts

Artificial Medical Intelligence
Stuart Covit, 866-415-6112
scovit@artificialmed.com
or
Results Public Relations
Elyse Familant, 978-725-3637
elysef@resultspr.net

Release Summary

Artificial Medical Intelligence announced a patent for Delphi Method Process for more accurate Computer Assisted Coding and faster implementation.

Contacts

Artificial Medical Intelligence
Stuart Covit, 866-415-6112
scovit@artificialmed.com
or
Results Public Relations
Elyse Familant, 978-725-3637
elysef@resultspr.net